Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 22Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4GlaxoSmithKline Inc.

02 11Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name : ZANTAC EFFERVESCENT

Patent Number : 1329130

Filing Date :

Strength per Unit : 300 mg

Dosage Form : Granules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name : ZANTAC

Patent Number : 1329130

Filing Date :

Strength per Unit : 150 mg

Dosage Form : Granules

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name : ZANTAC

Patent Number : 1329130

Filing Date :

Strength per Unit : 150 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name : ZANTAC

Patent Number : 1329130

Filing Date :

Strength per Unit : 300 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-05-03

Date Granted : 1994-05-03

blank

05

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name :

Patent Number : 1202638

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-04-01

Date Granted :

blank

06

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name :

Patent Number : 1202638

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-04-01

Date Granted :

blank

07

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name :

Patent Number : 1202638

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-04-01

Date Granted :

blank

08

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name :

Patent Number : 1202638

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-04-01

Date Granted :

blank

09

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name :

Patent Number : 1202638

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-04-01

Date Granted :

blank

10

arrow
American Pharma Summit
Not Confirmed

Country
arrow
American Pharma Summit
Not Confirmed

Ranitidine Hydrochloride

Brand Name :

Patent Number : 1202638

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-04-01

Date Granted :

blank